CYP Isoforms Involved in the Metabolism of Clarithromycin in vitro: Comparison between the Identification from Disappearance Rate and that from Formation Rate of Metabolites-Reference-Cited by-同舟云学术

CYP Isoforms Involved in the Metabolism of Clarithromycin in vitro: Comparison between the Identification from Disappearance Rate and that from Formation Rate of Metabolites

Published:2003 Issue:2 Volume:18 Page:104-113
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Suzuki Akio,Iida Izumi,Hirota Mitsuyo,Akimoto Masayuki,Higuchi Shohei,Suwa Toshio,Tani Masayoshi,Ishizaki Takashi,Chiba Kan

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference36 articles.

1. Bacteriological evaluation of TE-031(A-56268), a new macrolide antibiotic: In vitro and in vivo antibacterial activity;Ono;Chemotherapy,1988

2. Clarithromycin: review of a new macrolide antibiotic with improved microbiological spectrum and favorable pharmacokinetic and adverse effect profiles;Surgill;Ann. Pharmacother.,1992

3. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study;Lind;Helicobacter,1996

4. Isolation and identification of metabolism of TE-031(A-56268) in human urine;Adachi;Chemotherapy,1988

5. Metabolism and disposition of clarithromycin in man;Ferrero;Drug Metab. Dispos.,1990

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism;Proceedings of the National Academy of Sciences;2024-02-05

2. Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism;Yonago Acta Medica;2024

3. Estimation of contribution of CYP2D6 to tipepidine metabolism in humans and prolongation of the half-life of tipepidine by combination use with a CYP2D6 inhibitor in chimeric mice with humanised liver;Xenobiotica;2023-04-03

4. Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo;Pharmaceutical Biology;2023-02-02

5. Identification of Antibiotics in Surface-Groundwater. A Tool towards the Ecopharmacovigilance Approach: A Portuguese Case-Study;Antibiotics;2021-07-21